Authors:
LAMY T
BERNARD M
COURTOIS A
JACQUELINET C
CHEVRIER S
DAURIAC C
GRULOIS I
GUIGUEN C
LEPRISE P
Citation: T. Lamy et al., PROPHYLACTIC USE OF ITRACONAZOLE FOR THE PREVENTION OF INVASIVE PULMONARY ASPERGILLOSIS IN HIGH-RISK NEUTROPENIC PATIENTS, Leukemia & lymphoma, 30(1-2), 1998, pp. 163-174
Authors:
AMIOT L
FARDEL O
DRENOU B
LEBERRE C
DAURIAC C
BEAUPLET A
LAMY T
FAUCHET R
Citation: L. Amiot et al., IN-VITRO DETERMINATION OF HEMATOPOIETIC PROGENITOR CONTENT OF AUTOGRAFTS - COMPARISON OF CD-34 NUMBERS AND CLONOGENIC ASSAYS, Bone marrow transplantation, 21, 1998, pp. 646-646
Authors:
AMIOT L
ONNO M
LAMY T
DAURIAC C
LEPRISE PY
FAUCHET R
DRENOU B
Citation: L. Amiot et al., LOSS OF HLA MOLECULES IN B-LYMPHOMAS IS ASSOCIATED WITH AN AGGRESSIVECLINICAL COURSE, British Journal of Haematology, 100(4), 1998, pp. 655-663
Authors:
JOURDAN E
MARANINCHI D
REIFFERS J
GLUCKMAN E
RIO B
JOUET JP
MICHALLET M
MOLINA L
ARCHIMBAUD E
HAROUSSEAU JL
IFRAH N
ATTAL M
GUILHOT F
KUENTZ M
GUYOTAT D
PICO JL
DAURIAC C
LEGROS M
DREYFUS F
BORDIGONI P
LEBLOND V
GRATECOS N
VARET B
AUZANNEAU C
TILLY H
VILMER E
BARDOU VJ
BLAISE D
Citation: E. Jourdan et al., EARLY ALLOGENEIC TRANSPLANTATION FAVORABLY INFLUENCES THE OUTCOME OF ADULT PATIENTS SUFFERING FROM ACUTE MYELOID-LEUKEMIA, Bone marrow transplantation, 19(9), 1997, pp. 875-881
Authors:
SUTTON L
CHASTANG C
RIBAUD P
JOUET JP
KUENTZ M
ATTAL M
REIFFERS J
TIGAUD JM
RIO B
DAURIAC C
LEGROS M
DREYFUS F
LIOURE B
TROUSSARD X
MILPIED N
WITZ F
ORIOL P
CAHN JY
MICHALLET M
GLUCKMAN E
IFRAH N
PICO JL
VILMER E
LEBLOND V
Citation: L. Sutton et al., FACTORS INFLUENCING OUTCOME IN DE-NOVO MYELODYSPLASTIC SYNDROMES TREATED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION - A LONG-TERM STUDY OF 71 PATIENTS, Blood, 88(1), 1996, pp. 358-365
Authors:
LAMY T
DRENOU B
GRULOIS I
FARDEL O
JACQUELINET C
GOASGUEN J
DAURIAC C
AMIOT L
BERNARD M
FAUCHET R
LEPRISE PY
Citation: T. Lamy et al., MULTIDRUG-RESISTANCE (MDR) ACTIVITY IN ACUTE-LEUKEMIA DETERMINED BY RHODAMINE-123 EFFLUX ASSAY, Leukemia, 9(9), 1995, pp. 1549-1555
Authors:
JOURDAN E
MARANINCHI D
REIFFERS J
ARCHIMBAUD E
MICHALLET M
HAROUSSEAU JL
IFRAH N
RIO B
GUYOTAT D
GUILHOT F
ATTAL M
LEBLOND V
DAURIAC C
LEGROS M
PICO JL
MARIT G
BLAISE D
Citation: E. Jourdan et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION REMAINS AN EFFICIENT CONSOLIDATION FOR ADULTS WITH ACUTE MYELOID-LEUKEMIA EVEN WHEN PERFORMED VERY SOON AFTER DIAGNOSIS (LESS-THAN-100 DAYS), Leukemia, 9(6), 1995, pp. 1068-1071
Authors:
DEBOUCHONY ET
LEBERRE C
DAURIAC C
GENETET N
LAPART C
FAUCHET R
LEPRISE PY
GENETET B
RAFFOUX C
SEMANA G
Citation: Et. Debouchony et al., RELEVANCE OF 10 CAUCASIAN HLA HAPLOTYPES IN SEARCHES FOR UNRELATED BONE-MARROW DONORS FOR 100 PATIENTS FROM A SINGLE-CENTER, Bone marrow transplantation, 15(6), 1995, pp. 845-851
Authors:
DEVERGIE A
BLAISE D
ATTAL M
TIGAUD JD
JOUET JP
VERNANT JP
BORDIGONI P
IFRAH N
DAURIAC C
CAHN JY
LIOURE B
TROUSSARD X
REIFFERS J
GRATECOS N
MILPIED N
BELANGER C
GUYOTAT D
TILLY H
MICHALLET M
GLUCKMAN E
Citation: A. Devergie et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA IN FIRST CHRONIC PHASE - A RANDOMIZED TRIAL OF BUSULFAN-CYTOXAN VERSUS CYTOXAN-TOTAL-BODY IRRADIATION AS PREPARATIVE REGIMEN - A REPORT FROM THE FRENCH-SOCIETY-OF-BONE-MARROW-GRAFT (SFGM), Blood, 85(8), 1995, pp. 2263-2268
Authors:
LAMY T
DRENOU B
GRULOIS I
LEBERRE C
DAURIAC C
AMIOT L
GODARD M
FAUCHET R
LEPRISE PY
Citation: T. Lamy et al., IMPROVEMENT OF HEMATOLOGIC RECOVERY AFTER HIGH-DOSE INTENSIFICATION USING PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) MOBILIZED BY CHEMOTHERAPY AND GM-CSF, Annals of hematology, 69(6), 1994, pp. 297-302
Citation: T. Lamy et al., PROLONGED REMISSION AFTER BLASTIC PHASE RELAPSE OF CHRONIC MYELOGENOUS LEUKEMIA FOLLOWING BMT, Bone marrow transplantation, 13(1), 1994, pp. 105-106
Authors:
LAMY T
DRENOU B
GRULOIS I
AMIOT L
FARDEL O
GOASGUEN J
DAURIAC C
FAUCHET R
LEPRISE PY
Citation: T. Lamy et al., P-GLYCOPROTEIN (PGP), P110 AND CD34 EXPRESSION AND EVALUATION OF MDR ACTIVITY (DETERMINED BY RHODAMINE-123 EFFLUX) IN ACUTE MYELOID-LEUKEMIA (AML) - CLINICAL AND BIOLOGICAL SIGNIFICANCE, Blood, 84(10), 1994, pp. 10000044-10000044
Authors:
JOURDAN E
BLAISC D
REIFFERS J
GLUCKMAN E
RIO B
JOUET JP
MICHALLET M
ARCHIMBAUD E
HAROUSSEAU JL
IFRAH N
ATTAL M
GUILHOT F
KUENTZ M
GUYOTAT D
PICO JL
DAURIAC C
LEGROS M
DREYFUS F
BORDIGONI P
LEBLOND V
GRATECOS N
VARET B
AUZANNCAU C
TILLY H
VILMER E
MARANINCHI D
Citation: E. Jourdan et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ADULT WITH ACUTE MYELOID-LEUKEMIA IN 1ST COMPLETE REMISSION - A REPORT FROM THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE, Blood, 84(10), 1994, pp. 10000712-10000712
Authors:
BELANGER C
ESPEROUBOURDEAU H
BORDIGONI P
JOUET JP
SOUILLET G
MILPIED N
TROUSSARD X
KUENTZ M
HERVE P
REIFFERS J
DEMEOCQ F
DAURIAC C
BLAISE D
MICHALLET M
FIERE D
FREYCON F
GRATECOS N
RIO B
LEBLOND V
IFRAH N
ATTAL M
BERGERAT JP
VILMER E
PICO J
RAFFOUX C
CAUDRELIER P
GLUCKMAN E
Citation: C. Belanger et al., USE OF AN ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL-ANTIBODY FOR GVHD PROPHYLAXIS IN UNRELATED DONOR BMT, Bone marrow transplantation, 11(4), 1993, pp. 293-297
Authors:
LAMYA T
MICHELET C
DAURIAC C
GRULOIS I
DONIO PY
LEPRISE PY
Citation: T. Lamya et al., BENEFIT OF PROPHYLAXIS BY INTRAVENOUS SYSTEMIC VANCOMYCIN IN GRANULOCYTOPENIC PATIENTS - A PROSPECTIVE, RANDOMIZED TRIAL AMONG 59 PATIENTS, Acta haematologica, 90(3), 1993, pp. 109-113